Dose-escalating study of vandetanib in volunteers
Latest Information Update: 12 Jan 2012
At a glance
- Drugs Vandetanib (Primary)
- Indications Biliary cancer; Breast cancer; Prostate cancer; Thyroid cancer
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 12 Jan 2012 New trial record
- 27 Dec 2011 Results published in Clinical Therapeutics.